Suchergebnisse - "Pinato, David J"

PubPharm (7)

1

Diabetes and Immune Checkpoint Inhibitors-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Cortellini, A. | D'Alessio, A. | Pinato, D.

CommentOn: Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. - PMID 37125965

2

COSMIC-312 : mounting immunotherapy enigmas for hepatocellular carcinoma

enthalten in: The Lancet. Oncology | 2022

von Cabibbo, G. | Celsa, C. | D'Alessio, A. | +2

CommentOn: Lancet Oncol. 2022 Aug;23(8):995-1008. - PMID 35798016

3

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Pinato, D.

4

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Pinato, D.

5

Response to letter entitled : Re: Predictive ability of a drug-based score in advanced non-small cell lung cancer patients receiving first-line immunotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cortellini, A. | Bersanelli, M. | Pinato, D. | +1

CommentOn: Eur J Cancer. 2021 Jun;150:224-231. - PMID 33934059

6

Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer-Reply

enthalten in: JAMA oncology | 2020

von Pinato, D. | Newsom-Davis, T. | Bower, M.

CommentOn: JAMA Oncol. 2019 Dec 1;5(12):1774-1778. - PMID 31513236

7

Reply to : 'Validating the ALBI grade: Its current and future use in HCC prognostication'

enthalten in: Journal of hepatology | 2017

von Pinato, D. | Yen, C. | Sharma, R.

CommentOn: J Hepatol. 2017 Feb;66(2):338-346. - PMID 27677714

1
[1]